Morpholino A(Ceoc) subunit
Morpholino A(Ceoc) subunit - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.PR1-113
-
SMILESO=C(OCCC#N)NC1=NC=NC2=C1N=CN2C3OC(COP(Cl)(N(C)C)=O)CN(C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C3
-
Molecular FormulaC35H36ClN8O5P
-
Molecular Weight715.15
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityUPLC≥98%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.PR1-113
-
SMILESO=C(OCCC#N)NC1=NC=NC2=C1N=CN2C3OC(COP(Cl)(N(C)C)=O)CN(C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C3
-
Molecular FormulaC35H36ClN8O5P
-
Molecular Weight715.15
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityUPLC≥98%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
